These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 90214)

  • 1. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong.
    Newman RG; Whitehill WB
    Lancet; 1979 Sep; 2(8141):485-8. PubMed ID: 90214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone.
    Woody GE; O'Brien CP; Rickels K
    Am J Psychiatry; 1975 Apr; 132(4):447-50. PubMed ID: 1091161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative induction and crossover schedules for methadyl acetate.
    Ling W; Dorus W; Hargreaves WA; Resnick R; Senay E; Tuason VB
    Arch Gen Psychiatry; 1984 Feb; 41(2):193-9. PubMed ID: 6365017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal from methadone maintenance. Rate of withdrawal and expectation.
    Senay EC; Dorus W; Goldberg F; Thornton W
    Arch Gen Psychiatry; 1977 Mar; 34(3):361-7. PubMed ID: 843188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
    Bickel WK; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1988 Jan; 43(1):72-8. PubMed ID: 3275523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Efficacy and side effects of three widely different methadone doses.
    Goldstein A; Judson BA
    Proc Natl Conf Methadone Treat; 1973; 1():21-44. PubMed ID: 4612369
    [No Abstract]   [Full Text] [Related]  

  • 9. Detoxification of rehabilitated methadone-maintained patients.
    Cushman P; Dole VP
    JAMA; 1973 Nov; 226(7):747-52. PubMed ID: 4585339
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone maintenance treatment. Five years later--where are they now?
    Gearing FR
    Am J Public Health; 1974 Dec; 64 Suppl 12(12 Suppl):44-50. PubMed ID: 4429175
    [No Abstract]   [Full Text] [Related]  

  • 11. A methadone therapeutic community: a supplement to an ambulatory methadone maintenance unit.
    Grossman G
    Proc Natl Conf Methadone Treat; 1973; 1():622-7. PubMed ID: 4808211
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dosage use of methadone in extended detoxification: An experimental comparison.
    Wilson BK; Elms RR; Thomson CP
    Arch Gen Psychiatry; 1974 Aug; 31(2):233-6. PubMed ID: 4604708
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma testosterone levels in heroin addiction and during methadone maintenance.
    Mendelson JH; Mendelson JE; Patch VD
    J Pharmacol Exp Ther; 1975 Jan; 192(1):211-17. PubMed ID: 1123724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
    Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with a combination of group therapy and methadone maintenance in the treatment of heroin addiction.
    LaRosa JC; Lipsius SH; LaRosa JH
    Int J Addict; 1974; 9(4):605-17. PubMed ID: 4435971
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term methadone administration reduces alcohol consumption in non-alcoholic heroin addicts.
    Caputo F; Addolorato G; Domenicali M; Mosti A; Viaggi M; Trevisani F; Gasbarrini G; Bernardi M; Stefanini GF;
    Alcohol Alcohol; 2002; 37(2):164-8. PubMed ID: 11912072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.
    Peles E; Schreiber S; Hetzroni T; Adelson M; Defrin R
    J Pain; 2011 Jan; 12(1):41-50. PubMed ID: 20561825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
    Sacerdote P; Franchi S; Gerra G; Leccese V; Panerai AE; Somaini L
    Brain Behav Immun; 2008 May; 22(4):606-13. PubMed ID: 18294814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.
    D'Ippoliti D; Davoli M; Perucci CA; Pasqualini F; Bargagli AM
    Drug Alcohol Depend; 1998 Oct; 52(2):167-71. PubMed ID: 9800146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.